chrisdorney / Shutterstock.com
The UK’s Competition and Markets Authority (CMA) has imposed fines of £260 million on drug companies for raising the price of life-saving hydrocortisone tablets by 10,000%.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
CMA, hydrocortisone, Auden Mckenzie, Actavis UK, Accord, NHS, drug prices, fines